You are going to worry yourself sick Bob. Look at it this way: four BLAs will be submitted and NWBO will not run out of funds before at least one of the RAs approves. So, in the end, we can be confident that cancer patients will have access to the vaccine and the market cap will true up eventually. All this other stuff in between now and then is fluff. Who knows, LP and the execs at Merck may have already agreed in principle on a BO.
Market Data 
Markets 
AI
